Obesity care startup Ilant Health raises $15Mnews2026-06-02T10:00:23+00:00June 2nd, 2026|Endpoints News|
Updated: Allen Institute launches $400M effort to turn brain atlas lessons into medicinesnews2026-06-02T09:00:42+00:00June 2nd, 2026|Endpoints News|
The cost of a PRV is twice as high as it was three years ago — and it’s likely to stay that way news2026-06-01T18:58:22+00:00June 1st, 2026|Endpoints News|
Epigenetic editing shows promise against chronic hep B infectionsnews2026-06-01T18:48:12+00:00June 1st, 2026|Endpoints News|
Shionogi wins US approval for first pill to prevent Covid following exposurenews2026-06-01T16:50:44+00:00June 1st, 2026|Endpoints News|
#ASCO26: Lilly’s plenaries; Incyte’s frontline data in lymphomanews2026-06-01T15:58:19+00:00June 1st, 2026|Endpoints News|
Agios licenses Oscotec drug; CEPI funds three potential Ebola vaccinesnews2026-06-01T14:39:37+00:00June 1st, 2026|Endpoints News|
#ASCO26: Kelonia Therapeutics delivers an impressive in vivo CAR-T updatenews2026-06-01T14:29:34+00:00June 1st, 2026|Endpoints News|
After being ditched by Candid, Rallybio finds Avenzo to take its Nasdaq listingnews2026-06-01T14:11:13+00:00June 1st, 2026|Endpoints News|
Turn Therapeutics’ eczema drug shows rapid response in mid-stage datanews2026-06-01T12:51:57+00:00June 1st, 2026|Endpoints News|
